AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Rachel Melcer
Mar. 21--Monsanto Co. said Monday it is beginning in-house production of Posilac, which should ease a two-year-old shortage of the hormone used to boost milk production in cows.
The Creve Coeur company received approval from the U.S. Food and Drug Administration to begin formulating and packaging Posilac bovine somatotropin at its plant in Augusta, Ga.
Since 2003, the facility has manufactured the Posilac active ingredient and shipped it for final production to Sandoz GmbH, an Austrian subsidiary of Novartis AG.
Monsanto has been rationing Posilac since December 2003, when Sandoz, its lone supplier, had quality ...
Source: HighBeam Research, Monsanto takes over production of milk hormone.